Anna Klawonn studies how immune signals and neuromodulators reshape striatal and serotonergic circuits to govern affect, reward learning, and pain aversion. Combines chemogenetics, imaging, electrophysiology, and behavioral models; translational links to depression, addiction, and Parkinson’s, with academic and pharma partners.